Effects of a Whole Body Vibration Training in Patients After Lung Transplantation
Information source: Klinikum Berchtesgadener Land der Schön-Kliniken
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Patients Following Lung Transplantation (Single and Double)
Intervention: Pulmonary rehabilitation + whole body vibration training (Other)
Phase: N/A
Status: Recruiting
Sponsored by: Klinikum Berchtesgadener Land der Schön-Kliniken Overall contact: Klaus Kenn, Dr. med., Phone: 0049865293, Ext: 1540, Email: kkenn@schoen-kliniken.de
Summary
Pulmonary rehabilitation has been established as an evidence-based and recommended therapy
in patients following lung transplantation. Exercise training has been shown to be a
cornerstone of an inpatient rehabilitation program to reduce muscle dysfunction and improve
exercise performance. In our study we will investigate the benefit of a whole body vibration
training in addition to a standard pulmonary rehabilitation program that includes endurance
and strength training. We will include a total of 140 patients (70 patients < 1 year after
lung Transplantation and 70 patients > 1 year after lung Transplantation). Our hypothesis is
that an addtitional whole body vibration training produces a greater benefit to exercise
capacity in lung transplantat patients (LTx).
Clinical Details
Official title: Effects of a Whole Body Vibration Training on the Exercise Performance in Patients After Lung Transplantation
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary outcome: change in 6-minute walking distance
Secondary outcome: change in Wmaxchange in Fmax change in fibre cross sectional area change in chair rise time change in quality of life change in body cell mass change in IGF-1
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- participation in an inpatient rehabilitation program
- double or single lung transplantation due to chronic obstructive pulmonary disease,
Alpha-1-antitrypsine deficiency, interstitial lung disease
Exclusion Criteria:
- severe exacerbation in the last 4 weeks with the necessity of delivering antibiotics/
corticosteroids
- non-compliance
Locations and Contacts
Klaus Kenn, Dr. med., Phone: 0049865293, Ext: 1540, Email: kkenn@schoen-kliniken.de
Schön Klinik Berchtesgadener Land, Schönau am Königssee 83471, Germany; Recruiting Inga Heinzelmann, MSc, Sub-Investigator Rainer Glöckl, MSc, Sub-Investigator
Additional Information
Starting date: January 2012
Last updated: December 12, 2014
|